NOTICE: Due to upcoming U.S. tariff changes taking effect as early as August 29, postal services are updating shipping requirements, if applicable. Please expect shipping delays during this transition. Changes to orders will be communicated before shipping.
search

Actoplus Met

PIOGLITAZONE HCL/METFORMIN HCL
*The product shipped may have different packaging depending on supplier/strength chosen

Actoplus Met

REQUIRED
PIOGLITAZONE HCL/METFORMIN HCL
Select Strength
BRAND
United Kingdom
Marketed as Competact in the United Kingdom Manufactured by: Takeda

Select Quantity
Other Actoplus Met Options for Purchase:
Type
Product
Manufacturer
Country
Qty-price (USD)

ActoPlus Met: Dual-Action Diabetes Management

Control Blood Sugar with a Powerful Combination

ActoPlus Met (pioglitazone/metformin) is a prescription medication designed to help individuals with type 2 diabetes manage their blood sugar levels more effectively. By combining two proven diabetes treatments, ActoPlus Met enhances insulin sensitivity while reducing glucose production, providing a comprehensive approach to diabetes care.

Improve Insulin Sensitivity and Reduce Glucose Production

This medication works by lowering blood sugar in two ways: pioglitazone helps the body use insulin more efficiently, while metformin decreases glucose production in the liver. Together, they help maintain stable blood sugar levels and improve long-term diabetes control.

Easy-to-Take Tablet for Daily Use

ActoPlus Met is taken as a simple oral tablet, making it convenient for daily diabetes management. When combined with a healthy diet and exercise, it helps patients achieve better glycemic control and reduces the risk of diabetes-related complications.